Clonidine Extended-Release Tablets and Kisqali (200 MG Dose)
Determining the interaction of Clonidine Extended-Release Tablets and Kisqali (200 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: clonidine
Brand name: Catapres, Kapvay, Catapres-TTS, Duraclon, Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3
Synonyms: Clonidine, CloNIDine
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Clonidine Extended-Release Tablets-Kisqali (400 MG Dose)
- Clonidine Extended-Release Tablets-Kisqali (600 MG Dose)
- Clonidine Extended-Release Tablets-Kisqali Femara Co-Pack
- Clonidine Extended-Release Tablets-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Clonidine Extended-Release Tablets-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Clonidine Extended-Release Tablets-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Kisqali (200 MG Dose)-Clonidine injection
- Kisqali (200 MG Dose)-Clonidine Oral, Transdermal
- Kisqali (200 MG Dose)-Clonidine Patch
- Kisqali (200 MG Dose)-Clonidine Patches
- Kisqali (200 MG Dose)-Clonidine Tablets
- Kisqali (200 MG Dose)-Clonidine transdermal